ADG-106 Antibody
ADG-106 is a fully human anti-CD137 (4-1BB) monoclonal antibody developed for cancer immunotherapy. It functions by inducing FcγRIIB-dependent agonism and ligand blockade, promoting T-cell activation. Its anti-tumor efficacy is being evaluated in preclinical in vitro and in vivo studies.
Product Specifications
Product Name Alternative
ADG106
Target
Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
10.1 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.72 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog